SUSTAINED LOW-DOSE LEVODOPA THERAPY IN PARKINSON'S DISEASE: A 3-YEAR FOLLOW-UPLEES AJ; STERN GM.1983; ADVANCES IN NEUROLOGY; ISSN 0091-3952; USA; DA. 1983; VOL. 37; PP. 9-15; BIBL. 19 REF.Article

SUSTAINED BROMOCRIPTINE THERAPY IN PREVIOUSLY UNTREATED PATIENTS WITH PARKINSON'S DISEASELEES AJ; STERN GM.1981; J. NEUROL. NEUROSURG. PSYCHIATRY; ISSN 0022-3050; GBR; DA. 1981; VOL. 44; NO 11; PP. 1020-1023; BIBL. 9 REF.Article

HISTOCOMPATIBILITY ANTIGENS AND POST-ENCEPHALITIC PARKINSONISMLEES AJ; STERN GM; COMPSTON DAS et al.1982; JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY; ISSN 0022-3050; GBR; DA. 1982; VOL. 45; NO 11; PP. 1060-1061; BIBL. 6 REF.Article

BACLOFEN IN PARKINSON'S DISEASE.LEES AJ; SHAW KM; STERN GM et al.1978; J. NEUROL. NEUROSURG. PSYCHIATRY; GBR; DA. 1978; VOL. 41; NO 8; PP. 707-708; BIBL. 15 REF.Article

INTRAMEDULLARY NAILING OF FEMORAL FRACTURES WITHOUT PRIOR REAMINGLEVY M; GOLDBERG I; STERN GM et al.1980; ORTHOP. REV.; ISSN 0094-6591; USA; DA. 1980; VOL. 9; NO 7; PP. 61-67; BIBL. 23 REF.Article

LEVODOPA INDUCED CHOREA IN MEIGE SYNDROMEHARDIE RJ; LEES AJ; STERN GM et al.1983; JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY; ISSN 0022-3050; GBR; DA. 1983; VOL. 46; NO 3; PP. 286; BIBL. 4 REF.Article

PHENYLACETIC ACID IN HUMAN BODY FLUIDS: HIGH CORRELATION BETWEEN PLASMA AND CEREBROSPINAL FLUID CONCENTRATION VALUESSANDLER M; RUTHVEN CRJ; GOODWIN BL et al.1982; J. NEUROL. NEUROSURG. PSYCHIATRY; ISSN 0022-3050; GBR; DA. 1982; VOL. 45; NO 4; PP. 366-368; BIBL. 20 REF.Article

CHIP FRACTURE OF THE OS TRIQUETRUMLEVY M; FISCHEL RE; STERN GM et al.1979; J. BONE JOINT SURG., BRIT. ED.; GBR; DA. 1979; VOL. 61; NO 3; PP. 355-357; BIBL. 5 REF.Article

ELECTROCONVULSIVE THERAPY IN PARKINSONIAN PATIENTS WITH THE "ON-OFF" SYNDROMEWARD C; STERN GM; PRATT RTC et al.1980; J. NEURAL TRANSM.; ISSN 0300-9564; AUT; DA. 1980; VOL. 49; NO 1-2; PP. 133-135; BIBL. 5 REF.Article

THE EFFECT OF DEPRENYL, A SELECTIVE MONOAMINE OXIDASE B INHIBITOR, ON SLEEP AND MOOD IN MANTHORNTON C; DORE CJ; ELSWORTH JD et al.1980; PSYCHOPHARMACOLOGY; DEU; DA. 1980; VOL. 70; NO 2; PP. 163-166; BIBL. 21 REF.Article

DEPRENYL IN PARKINSON'S DISEASE.LEES AJ; SHAW KM; KOHOUT LJ et al.1977; LANCET; G.B.; DA. 1977; NO 8042; PP. 791-795; BIBL. 18 REF.Article

DEPRENYL IS METABOLIZED TO METHAMPHETAMINE AND AMPHETAMINE IN MANREYNOLDS GP; ELSWORTH JD; BLAU K et al.1978; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1978; VOL. 6; NO 6; PP. 542-544; BIBL. 18 REF.Article

ENDOCRINE ASPECTS OF BROMOCRIPTINE THERAPY IN PARKINSONISMSHAW KM; LEES AJ; FRANKS S et al.1978; J. NEUR. TRANSM.; AUT; DA. 1978; VOL. 43; NO 2; PP. 153-160; BIBL. 2 P.Article

DEPRENYL ADMINISTRATION IN MAN: A SELECTIVE MONOAMINE OXIDASE B INHIBITOR WITHOUT THE "CHEESE EFFECT".ELSWORTH JD; GLOVER V; REYNOLDS GP et al.1978; PSYCHOPHARMACOLOGY; GERM.; DA. 1978; VOL. 57; NO 1; PP. 33-38; BIBL. 29 REF.Article